• 2026 Agenda
  • Advisory Board
  • 2026 Speakers
  • Plan Your Visit
  • Event Gallery
  • 2027 Sponsors
  • Media Centre
  • Resources
  • Why partner?
  • Contact Us

WHAT TO EXPECT FOR 2027?

As clinical trials continue to evolve, 2027 brings new challenges and opportunities across clinical operations, technology, regulation and patient engagement. OCT West Coast will bring the industry together to explore what is changing, what is working and what clinical trial teams need to be thinking about next.

Expect practical insights, honest discussions and real-world experiences from leaders across pharma, biotech and the wider clinical trial community. From navigating regulatory change and making the most of new technologies to improving trial efficiency, strengthening partnerships and putting patients at the center, the agenda will focus on the issues shaping clinical development today.

With a strong focus on collaboration and sharing practical experiences, OCT West Coast is an opportunity to connect with the region’s leading pharma and biotech companies, exchange ideas and explore new approaches to delivering smarter, more efficient and patient-focused clinical trials.

800+

Attendees

100+

Exhibitors

70+

Speakers

80%

Attendees at Director + Level
800+

Attendees

100+

Exhibitors
70+

Speakers

80%

Attendees at Director + Level

Testimonials

See What It's All About

2027 Sponsors Include:

Back

Company Information

ICON Biotech is a world leading healthcare intelligence and clinical research organisation, dedicated to the needs of small and mid-sized biopharma companies. We help biotech organisations meet their critical milestones and deliver data and evidence-based results to investors, large pharma partners and regulatory authorities. With over 8,000 staff working exclusively with biotech customers, we support over 500 biotech sponsors annually.

 

ICON Biotech advances clinical research by offering highly focused, integrated outsourced services and solutions, delivered by tailored teams and management that understand the different pressures faced by biotechs in their drive to solve today’s challenges, without losing sight of their mission to deliver life-changing innovations tomorrow. To learn more, please visit www.iconplc.com/biotech

 

Next Sponsor
Back

Company Information

Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug development. With deep therapeutic and regulatory expertise and an expansive global footprint across the Asia-Pacific region, North America, and Europe, Novotech offers clients an accelerated path to bring life-changing therapies to market.

Company Website

To learn more, please visit our website - www.novotech-cro.com

Next Sponsor
Back

Company Information

Biorce builds AI infrastructure for clinical trials. Our platform, Aika, accelerates how pharmaceutical companies, biotechs, and CROs design and execute clinical research—reducing protocol development time by at least 50% while eliminating costly amendments that delay patient access to life-saving treatments. Built on a foundation of 1 million clinical trials, Aika delivers evidence-based recommendations with complete regulatory transparency. Every decision auditable and defensible before agencies like the FDA and EMA.

Company Website

To learn more, please visit our website - https://www.biorce.com/

Next Sponsor
Back

Company Information

Caidya is a multi-therapeutic clinical research organization (CRO) serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making. Formed in 2021 following the merger of leading CROs, dMed and Clinipace, Caidya has nearly 1,800 employees in 30+ countries throughout the world.

Company Website

To learn more, please visit our website - www.Caidya.com

Next Sponsor
Back

Company Information

EPS Corporation, an EPS Holdings Group Company, a Japanese headquartered company, is a comprehensive provider of clinical research outsourced services. Since 1991, the EPS Group has grown to over 7,800 staff providing quality R&D support to pharmaceutical, biotech, regenerative medicine, and medical device companies. EPS operates in Japan, China, South Korea, and Taiwan. With a business partner, we also support studies in other Asia-Pacific countries.

Company Website

To learn more, please visit our website - https://www.eps-holdings.co.jp/en/

Next Sponsor
Back

Company Information

Founded in 1997, Ergomed is a full service, global Phase I-IV clinical development and trial management service partner with leading expertise in developing oncology and rare disease drugs.  Our portfolio includes experience working with novel therapies, early phase development, immunotherapy, and adaptive trial designs. Ergomed embodies a patient-centric approach to recruitment and retention with access to global patients in vital geographical areas.  Ergomed’s proven delivery record, expertise, and true partnership means our sponsors can trust us to deliver their oncology trials whatever the challenge. We also offer an industry-leading suite of specialist pharmacovigilance (PV) solutions under the PrimeVigilance brand.

Ergomed has supported and managed clinical development, trial management, pharmacovigilance, and medical information services for over 300 clients in more than 100 countries.

We deliver a complete solution for oncology trials of all sizes and complexity. For more information about Ergomed, please visit: www.ergomedcro.com

Company Website

To learn more, please visit our website - www.ergomedcro.com

Next Sponsor
Back

Company Information

Fortrea is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas. Our talented and diverse team of more than 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally.

Company Website

To learn more, please visit our website - https://www.fortrea.com/

Next Sponsor
Back

Company Information

MRN is focused on the delivery of patient-centric clinical trials. Through our at-home, at-site and digital decentralized trials solutions we help our pharma and site partners design more flexible and accessible clinical trials allowing them to accelerate patient recruitment and enrollment and improve patient engagement and retention around the globe.

Company Website

To learn more, please visit our website - https://themrn.io/

Next Sponsor
Back

Company Information

MedPoint Digital develops intuitive, ICH-GCP compliant eClinical platforms for virtual investigator meetings, trial portals, interactive modules, and virtual clinical trials. Our digital solutions enable sites to be more productive, with online study training, study eBinders (eISF), digital study alerts and SUSARs, patient visit guides, and a wide range of study tools, available via web portals and mobile apps.

Company Website

To learn more, please visit our website - www.medpt.com

Next Sponsor
Back

Company Information

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. We work With HeartTM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference.

Company Website

To learn more, please visit our website - https://www.parexel.com/

Next Sponsor
Back

Company Information

Premier Research International LLC (Premier) is a leading global CRO and consulting partner with expertise in driving a smarter, faster path to approval. Our integrated approach helps the life sciences industry turn breakthrough science into life-changing drugs, devices, and diagnostics by addressing trial complexity, overcoming development hurdles, and demonstrating product value. 

Company Website

To learn more, please visit our website - https://premier-research.com/

Next Sponsor
Back

Company Information

PSI is a privately-owned, full-service contract research organization (CRO), operating globally. PSI’s reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries.

Company Website

To learn more, please visit our website - http://www.psi-cro.com/

Next Sponsor
Back

Company Information

Trialbee is the leading global data and technology platform for patient matching and enrollment in clinical trials. Partnering with sponsors, CROs, sites, and software providers, Trialbee is achieving patient enrollment goals and driving diversity in clinical trials. We are the smartest way to match and enroll patients for your clinical trial.

Company Website

To learn more, please visit our website - trialbee.com

Next Sponsor
Back

Company Information

Precision medicine is in our blood, our cells, our genes, and our name. Precision for Medicine (PFM), the full-service global CRO, is purpose-built to accelerate clinical research and development processes to bring life-changing therapeutics to those who need them most. We integrate clinical operations excellence, laboratory expertise, and advanced data sciences to deliver on the promise of personalized therapy; translating research into real-world results and forever reimaging how to get there.

Company Website

To learn more, please visit our website - www.precisionformedicine.com

Next Sponsor
Back

Company Information

Trial Library is a mission-driven, AI-enabled health technology company dedicated to improving health equity in cancer care by expanding access to precision medicine through clinical trials. We work with community oncology sites, patients, and industry partners to accelerate enrollment and retention and ensure clinical research is accessible, navigable, and inclusive.

Company Website

To learn more, please visit our website - https://www.triallibrary.com/

Next Sponsor
Back

Company Information

P95 Julius Clinical is a global, science-led CRO delivering integrated clinical development and real-world evidence solutions across five continents. Combining deep expertise in infectious diseases, vaccines, neuroscience, and cardio-renal-metabolic research, we support both full-service and modular approaches across the entire development lifecycle and post-marketing phases for pharmaceutical, biotech, and public health partners. With regional hubs in Africa, Latin America, North America, Southeast Asia, and Europe, we operate with a team of 500 professionals and over 25 years of collective experience. Guided by flexibility, client focus, and excellence, we deliver solutions that make a meaningful impact on public health worldwide.

URL: The therapeutically specialized CRO | Julius Clinical

 

Next Sponsor
Back

Company Information

IQVIA delivers AI‑powered clinical technologies that simplify trial operations, improve patient and site experiences, and accelerate clinical development. Our secure, SaaS‑based platforms use healthcare‑grade AI to streamline workflows, reduce administrative burden, and enable smarter, faster decision‑making across the clinical trial lifecycle.

Company Website

To learn more, please visit our website - https://www.iqvia.com/solutions/technologies

Next Sponsor
Back

Company Information

ACM Global Laboratories is one of the largest global independent central labs in the industry. ACM is certified by the College of American Pathologists (CAP) and the Substance Abuse and Mental Health Services Administration (SAMHSA). The company delivers high-quality laboratory testing and diagnostic lab services in support of both clinical trials research, toxicology and individual patient care. ACM provides a powerful combination of operational excellence, scientific expertise and unsurpassed global service to customers in more than 65 countries. ACM performs more than 20 million laboratory tests each year—spanning all medical disciplines including pathology, microbiology, molecular diagnostics, toxicology and more.

Company Website

To learn more, please visit our website - www.ACMGlobalLab.com

Next Sponsor
Back

Company Information

Founded in 2005, Inspire connects life sciences organizations with the voices that matter most—patients and caregivers. With 10 million unique annual visitors across over 3,000 disease states, Inspire leverages its engaged patient communities to accelerate clinical trial recruitment, uncover real-world evidence, deliver actionable market research, and provide targeted advertising solutions for health-focused audiences.  By bridging the gap between patients and life sciences, Inspire enables smarter decision-making and a deeper understanding of the communities it serves.

Company Website

To learn more, please visit our website - https://inspireresearch.com/

Next Sponsor
Back

Company Information

Advarra delivers the platform, insights, and expertise that make clinical trials more efficient and connected. We bring over 40 years of trusted IRB oversight, operational intelligence, and collaborative technology to the industry—streamlining study design, startup, and conduct for research sites, sponsors, and CROs worldwide. Learn more at www.advarra.com.

Next Sponsor

    2026 Agenda

    • 10 Feb 2027
    • 11 Feb 2027
    Expand All

    Streams

    Stream one

    Stream A: Outsourcing & Clinical Operations

    Stream two

    Stream B: Data, AI & Clinical Innovation

    Stream three

    Stream C: Biotech Strategy

    11:15 AM

    Doing More with Less: How Virtual Biotechs Can Successfully Conduct First Clinical Studies on a Budget

    • Stretching limited resources and deciding where a small, underfunded team can prioritize resources and save money without compromising clinical progress
    • Taking advantage of a not-for-profit CRO in Canada to build a lean operating model
    • Generating confidence in first-in-class programmes by building the clinical and safety evidence needed when there is little external validation
    • Breaking the funding catch-22: Turning early data into momentum by delivering meaningful proof points that can unlock further investment and move the programme towards its next stage

    Speakers

    Michael Weickert
    Ph.D, CEO, Pacylex Pharmaceuticals

    11:45 AM

    Session reserved for event sponsor

    12:15 PM

    CASE STUDY: When You Stop a Trial Midway, What Changes When You Start Again?

    A candid case study on pausing a clinical program, securing new funding and returning to the clinic with a sharper strategy, informed by what went wrong the first time.

    • Building a more decisive development strategy, from rapid dose escalation to a clearer path through the next phase
    • Taking tighter control of translational data and challenging vendors to deliver the evidence needed to make confident development decisions
    • Working closely with the FDA to explore accelerated development pathways and build a more efficient route back to the clinic in a high unmet-need indication
    • Applying the lessons from the first trial to design a more efficient, focused program

    Speakers

    Pamela Contag
    CEO and President, BioEclipse Therapeutics

    12:45 PM

    Session reserved for event sponsor

    1:15 PM

    Lunch and networking

    Sponsored by Thermo Fisher Scientific

    2:30 PM

    PANEL DISCUSSION: Why Clinical Trial Start-Up Still Takes So Long

    • Where are the biggest bottlenecks, from regulatory approvals to vendor onboarding, cross-functional alignment, and site activation?
    • Sharing practical approaches to accelerate study start-up while maintaining quality and compliance
    • How can sponsors, CROs, vendors, and sites collaborate earlier to prevent downstream delays before the first patient is enrolled?
    • Understanding why contract negotiations and expectation misalignment continue to delay site activation timelines

    Moderator: Available

    Seats available for biotech, pharma and event sponsor

    Speakers

    Yuyi Shen
    Vice President, Technical Operations, Abcuro

    3 PM

    Session reserved for event sponsor

    3:30 PM

    Afternoon refreshments and networking

    3:45 PM

    PRIZE DRAW

    Sponsored by Dr. Vince Clinical Research

    Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

    Entries from this prize draw will also be entered into the early birds prize draw at 9.20am on day 2, you must be present to win!

    4 PM

    When is the Right Time to Build Quality Management Systems

    • Determining the right stage of growth to implement formal quality management systems without slowing innovation
    • Building practical frameworks for vendor qualification and oversight selection processes
    • Streamlining essential documentation, including informed consent and SOP development
    • Identifying which quality processes are business-critical versus unnecessarily complex for lean biotechs

    Speakers

    Charisse Eary
    Executive Director, Head of Quality, Aligos Therapeutics

    11:15 AM

    Don’t Bolt a Jet Engine to the Horse Carriage: Designing AI-Native Workflows for Clinical Development

    • Rethinking clinical workflows from the ground up rather than simply adding AI to existing processes
    • Identifying where AI can genuinely reduce manual effort, improve decision-making and accelerate development
    • Exploring how data, technology and people need to work together to support AI-native operations
    • Sharing practical lessons for moving from isolated AI pilots to scalable, embedded workflows

    Speakers

    Megan L. Dunham
    Associate Director, Clinical Data Innovation, Jazz Pharmaceuticals

    11:45 AM

    Session reserved for event sponsor

    12:15 PM

    Beyond the AI Pilot: Scaling AI Across Clinical Development

    • How can biotechs implement AI tools and convince their internal teams to adopt it
    • Access to affordable innovation for companies on a smaller budget and how to best allocate limited resources
    • Sharing practical lessons from implementing Claude AI across a growing organization
    • Maintaining data security and confidentiality for GDPR and HIPAA while using AI tools

    Speakers

    Dave Borbas
    VP Research, Head of Data Management, Abcuro

    12:45 PM

    Session reserved for event sponsor

    1:15 PM

    Lunch and networking

    Sponsored by Thermo Fisher Scientific

    2:30 PM

    PANEL DISCUSSION: Future-Proofing Clinical Trials with AI

    • Exploring how AI can support end-to-end clinical trial delivery, from protocol authoring and risk assessment through to data analysis and reporting
    • Examining how regulatory feedback and operational data can be leveraged to improve planning and site strategy
    • Understanding how AI-driven connectivity across departments can break down silos and create a more integrated approach to trial execution
    • Discussing how organizations can operationalize AI strategically to future-proof clinical development processes

    Moderator: Available

    Seats available for biotech, pharma and event sponsor

    Speakers

    Dave Borbas
    VP Research, Head of Data Management, Abcuro

    3 PM

    Session reserved for event sponsor

    3:30 PM

    Afternoon refreshments and networking

    3:45 PM

    PRIZE DRAW

    Sponsored by Dr. Vince Clinical Research

    Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

    Entries from this prize draw will also be entered into the early birds prize draw at 9.20am on day 2, you must be present to win!

    4 PM

    PATIENT ORGANIZATION SPOTLIGHT – Placebo-Less Trials for Deadly Diseases: Building Regulatory-Grade Data Sets That Can Be Used for Clinical Trials

    • Accelerating remote monitoring and technology enabled trials through real world case studies
    • Discovering how tech not-for-profit, EverythingALS, is innovating clinical development
    • Identifying trial ready patients and predicting disease progression without traditional biomarkers
    • Integrating patient reported outcomes, speech, wearables and digital measures into clinical development

    Speakers

    Christian Rubio
    Executive Director, EverythingALS

    4:30 PM

    NEW FOR 2027! INTERACTIVE BEER BOARDROOM

    TRACK B: Beyond the Hype: Where Does AI Actually Belong in Clinical Trials?

    Participants work together in this collaborative session to separate genuine clinical value from AI hype, exploring where AI can meaningfully improve trial delivery and where human expertise remains essential

    • 5-minute problem statement introducing a sponsor considering AI across multiple areas of clinical trial delivery
    • 20-minute whiteboard exercise mapping where AI can add the most value across trial design, recruitment, operations, data and decision making
    • 5-minute table presentations comparing each group’s learnings and approaches from the session 

    Facilitator: Megan L. Dunham, Director, R&D AI Governance & Portfolio Strategy, Jazz Pharmaceuticals 

    Co-Facilitator: Available for event sponsor

    Speakers

    Megan L. Dunham
    Associate Director, Clinical Data Innovation, Jazz Pharmaceuticals

    END OF DAY 1 AND NETWORKING DRINKS

    7:30 AM

    Registration & Refreshments

    8:15 AM

    Chairperson’s opening remarks

    Speakers

    Robert Loll
    Senior Vice President, Business Development and Strategic Planning, Praxis

    8:30 AM

    KEYNOTE: Accelerating Drug Development with the 505(b)(2) Pathway: Smarter Clinical Strategies by Leveraging Existing Evidence

    • Exploring the growing reliance on the 505(b)(2) route and what it signals about evolving regulatory and development strategies
    • Practical insights on what works, common pitfalls, and how to successfully execute within a 505(b)(2) strategy
    • Identifying when 505(b)(2) is the right route and how it shapes clinical trial design, timelines, and investment strategy
    • Designing efficient trials within the 505(b)(2) framework and leveraging existing data while ensuring robust, targeted clinical evidence to support approval

    FDA invited

    9 AM

    Session reserved for featured sponsor

    9:30 AM

    PANEL DISCUSSION: Where Should You Run Your Next Clinical Trial? Opportunities And Challenges in USA, APAC And Beyond

    • Why are some countries moving faster than the US? Comparing regulatory and operational timelines across emerging trial destinations
    • Understanding where international technology and infrastructure are creating advantages
    • Deciding which countries to prioritize and which to avoid
    • Diving into the practical realities of managing multiple vendors, with strategies for maintaining consistency and compliance across borders

    Moderator: Meghal Vakil, Director, Regulatory Affairs, BeOne Medicines USA

    Seats available for biotech, pharma and event sponsor

    Speakers

    Meghal Vakil
    Director, Regulatory Affairs, BeOne Medicines USA
    Sarah Hamirani
    Portfolio Director, AbbVie
    Malinda Longphre
    Head of Clinical Operations, Attovia Therapeutics

    10 AM

    Session reserved for featured sponsor

    10:30 AM

    Morning refreshments and networking break

    11:15 AM

    Navigating Complexity: Reimagining Study Management in High-Stake Clinical Trials

    • Building agile and scalable study management strategies that can adapt as trials evolve
    • Managing shifting priorities, unexpected challenges and increasing operational complexity without losing momentum
    • Enabling clinical leaders to make more effective decisions in rapidly changing trial environments
    • Managing complex protocols, multiple vendors and global stakeholders while maintaining control of timelines, quality and execution

    Speakers

    Catherine Caserza
    Director, Clinical Operations, Daiichi Sankyo

    11:45 AM

    Session reserved for event sponsor

    12:15 PM

    FIRESIDE CHAT: What Sponsors Still Get Wrong About Patient-Centered Clinical Research

    • Moving beyond tokenistic engagement to meaningfully involve patients in trial design and decision-making
    • Understanding what creates real patient burden and designing studies around the realities of patients’ lives
    • Using patient insights and data to improve recruitment, retention and the overall trial experience
    • Challenging internal assumptions about what patients actually want, need and value from clinical research

    Moderator: Available

    Speakers

    Sarah Hamirani
    Portfolio Director, AbbVie
    Guinevere Valencia
    Associate Director, Global Patient Advocacy, Argenx

    12:45 PM

    Session reserved for technology spotlight

    1 PM

    Session reserved for technology spotlight

    1:15 PM

    Lunch and networking

    Sponsored by Thermo Fisher Scientific

    2:30 PM

    ASK THE EXPERTS: The Regulatory Questions You Should Have Asked Six Months Ago

    This is an audience-led panel where regulatory experts respond in real time to the most pressing submission challenges attendees are dealing with today. The conversation is driven by live Q&A with questions that have been submitted in person/via Slido during the session.

    Some questions the panel will cover:

    • What information regulators actually need at different stages of development
    • What sponsors can learn from countries achieving dramatically faster development timelines
    • Understanding new approaches to expedited IND and early development pathways
    • Building regulatory strategy into the trial before problems emerge

    Moderator: Shilpen Patel, Senior Vice President, Perspective Therapeutics

    Seats available for biotech, pharma and event sponsor

    Speakers

    Shilpen Patel
    Senior Vice President, Perspective Therapeutics
    Meghal Vakil
    Director, Regulatory Affairs, BeOne Medicines USA
    Chitra Sharma
    Senior Vice President, Development, Scribe Therapeutics

    3 PM

    Session reserved for event sponsor

    3:30 PM

    Afternoon refreshments and networking

    3:45 PM

    PRIZE DRAW

    Sponsored by Dr. Vince Clinical Research

    Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

    Entries from this prize draw will also be entered into the early birds prize draw at 9.20am on day 2, you must be present to win!

    4 PM

    Designing for Delivery: Building Operationally Feasible Clinical Trials

    • Mapping patient populations, site realities and regulatory requirements early to inform delivery
    • Building patient and site feasibility into protocol design to reduce complexity and burden
    • Stress testing recruitment, eligibility, visits, procedures, endpoints and timelines before finalization
    • Aligning data, technology, vendors and operational KPIs to identify risks and support scalable delivery

    Speakers

    Nicholas D’Amato
    Director of Clinical Operations, Vaxart

    4:30 PM

    NEW FOR 2027! INTERACTIVE BEER BOARDROOM

    TRACK A: How Can We Make Patient Participation Easier?

    Participants work together to rethink the patient enrolment journey for an early phase trial, identifying practical ways sponsors, sites and trial teams can improve recruitment and remove barriers to participation.

    • 5-minute problem statement introducing a realistic Phase I trial scenario where identifying and recruiting the right patient population is proving challenging
    • 20-minute whiteboard exercise where each table maps the patient journey from finding a trial through to screening and consent, identifying the biggest barriers and points of drop-off
    • 5-minute table presentations comparing each group’s learnings and approaches from the session

    Facilitator: Mamatha Reddy, Executive Director and Head of Clinical Operations, Infinimmune

    Co-Facilitator: Available for event sponsor

    Speakers

    Mamatha Reddy
    Executive Director and Head of Clinical Operations, Infinimmune

    5:30 PM

    Chairperson’s closing remarks

    END OF DAY 1 AND NETWORKING DRINKS

    Streams

    Stream one

    Stream A: Outsourcing & Clinical Operations

    Stream two

    Stream B: Data, AI & Clinical Innovation

    Stream three

    Stream C: Biotech Strategy

    9:30 AM

    Session reserved for

    Speakers

    Suyash Prasad
    President, Research and Development, Stealth Mode Biotech

    10 AM

    Session reserved for event sponsor

    10:30 AM

    Morning refreshments and networking break

    11:15 AM

    When Trials Go Off Track: How Clinical Operations Leaders Recover Timelines, Sites and Study Performance

    • Identifying early warning signs that timelines, recruitment or site performance are starting to slip
    • Deciding when to intervene, escalate or adapt the trial operating model
    • Recovering underperforming sites, recruitment plans and vendor delivery without compromising quality
    • Balancing speed, resources and risk when making critical decisions to get a trial back on track

    Speakers

    Sanjay Mourya
    Senior Director, Clinical Operations, Unicycive Therapeutics

    11:45 AM

    Session reserved for event sponsor

    12:15 PM

    VC SPOTLIGHT Standing Out in a Competitive and Crowded Clinical Trial Landscape

    • Optimizing clinical trial resources in a complex landscape
    • Your pipeline looks great. But can you actually execute it?
    • What does an optimal development strategy look like for biotechs today?
    • Understanding what investors want to see at different stages of development

    Speakers

    Omer Siddiqui
    Venture Partner and Senior Development Advisor, NeuroVC

    12:45 PM

    Lunch and networking

    9:30 AM

    LIVE DEBATE: Are Too Many AI Tools Holding Back Clinical Development?

    • Managing multiple AI tools that cannot communicate with one another
    • Understanding whether fragmented technology is limiting AI's potential
    • Building a complementary technology ecosystem
    • Asking whether sponsors, CROs and vendors need to rethink how technology is selected

    Moderator: Margot L. Goodkin, Vice President, Ophthalmology Clinical Development, Annexon

    Debater 1: Available for biotech/ pharma

    Debater 2: Available for event sponsor

    Speakers

    Margot L. Goodkin
    Vice President, Ophthalmology Clinical Development, Annexon

    10 AM

    Session reserved for event sponsor

    10:30 AM

    Morning refreshments and networking break

    11:15 AM

    Optimizing Remote Data Capture: New Trends and Technology in Data Acquisition

    • Incorporating innovative products and tools into your clinical trial for remote data capture
    • FDA regulatory guidance around data acquisition and collecting data in remote settings
    • Easing burden on patients through remote data collection: how to utilize these tools effectively
    • How new tools such as eCOA solve patient issues

    Session available

    11:45 AM

    Session reserved for event sponsor

    12:15 PM

    PANEL DISCUSSION: Why Innovation Fails to Scale at the Pilot Stage

    • Defining clear ownership, success metrics, and decision points at every stage of implementation
    • Exploring how sponsors, CROs, and technology partners can better align expectations and timelines
    • Is the industry too risk-averse to innovate properly?
    • Identifying when to pivot, pause, or scale innovations based on measurable impact and long-term feasibility

    Moderator: Available

    1 seat available for biotech, pharma and event sponsor

    Speakers

    Jenny Holt
    Chief Development Officer, Ray Therapeutics
    Megan L. Dunham
    Associate Director, Clinical Data Innovation, Jazz Pharmaceuticals

    12:45 PM

    Lunch and networking

    2 PM

    Session reserved for GlobalData

    2:30 PM

    Session reserved for event sponsor

    3 PM

    Afternoon refreshments, networking and prize draw

    3:30 PM

    Chair’s closing remarks and end of conference

    8 AM

    Registration and Refreshments

    8:30 AM

    Interactive Breakfast Breakout Discussions

    With drinks and refreshments, interactive breakout sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will run twice and be led by a table moderator and will focus on a different challenge within clinical trials. Breakout discussions are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

    Discussion 1

    Figuring Out the Right Complimentary Mix of Vendors for Your Study

    Moderator available

    Discussion 2

    Understanding New Regulatory Approaches to Expedited IND And Early Development Pathways

    Moderator available

    Discussion 3

    How Can Biotechs Run Lean Without Compromising Trial Delivery?

    Moderator available

    Discussion 4

    Revolutionizing HealthTech: Confidently Leveraging the Latest Technologies to Accelerate Clinical Trials

    Moderator available

    9:20 AM

    Chair’s opening remarks and early birds prize draw

    The prize draw will take place in TRACK A: Outsourcing and Clinical Operations

    Entries from the day 1 prize draw will be entered into the draw. You must be present to win!

    9:30 AM

    The Cost of Delay: How Contracts and Budgets Can Make or Break Trial Timelines

    • Identifying contract and budget bottlenecks that can delay study start-up and execution
    • Exploring how slow negotiations, unclear scopes and change orders impact trial timelines
    • Aligning sponsors, CROs and sites on budgets, responsibilities and expectations from the outset
    • Sharing practical strategies to resolve financial and contractual roadblocks before they become costly delays

    Speakers

    Axel Van Chee
    Associate Director, Investigator Budgets & Payments – Clinical Operations, Exelixis
    Christopher Shinn
    Senior Director and Counsel, Contracts, Exelixis

    10 AM

    Session reserved for event sponsor

    10:30 AM

    Morning refreshments and networking break

    11:15 AM

    Session reserved

    Speakers

    Meghan McKenzie
    Director, AIR Portfolio Alliance Lead, Population Science, Genentech

    11:45 AM

    Session reserved for event sponsor

    12:15 PM

    PANEL DISCUSSION: Taking Control of Your CRO Strategy

    • Navigating CRO selection and choosing partners that fit your stage, study needs and growth plans
    • Deciding what to outsource, what to retain in-house and when an FSP model makes sense
    • Managing multiple CROs, systems, data standards and SOPs without creating unnecessary complexity
    • Protecting timelines and continuity through CRO consolidation and vendor transitions

    Moderator: Margot L. Goodkin, Vice President, Ophthalmology Clinical Development, Annexon

    1 seat available event sponsor

    Speakers

    Margot L. Goodkin
    Vice President, Ophthalmology Clinical Development, Annexon
    Abhijit Ramachandran
    Director, Clinical Development Operations – Oncology, Corcept Therapeutics
    Sue Naim
    Senior Vice President, Clinical Operations, Mirum Pharmaceuticals
    Anirban Mukherjee
    Vice President, Strategic Sourcing, Vera Therapeutics

    12:45 PM

    Lunch and networking

    2 PM

    One Trial, Many Partners: Building a Governance Model That Strengthens Vendor Partnerships

    • Clarifying accountability, decision-making and escalation across partners
    • Aligning vendors around shared goals, timelines and quality expectations
    • Using real-time data to identify risks and intervene earlier
    • Adapting governance as trial complexity and vendor needs evolve
    • Creating greater transparency across the vendor ecosystem

    Speakers

    Anirban Mukherjee
    Vice President, Strategic Sourcing, Vera Therapeutics

    2:30 PM

    Session reserved for event sponsor

    3 PM

    Afternoon refreshments, networking and prize draw

    3:15 PM

    PRIZE DRAW

    Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

    2026 Speakers

    Select a speaker to learn more

    Back
    Kiran Palukuri
    Director, Clinical Development Operations, 92Bio
    Next speaker
    Back
    Sarah Hamirani
    Portfolio Director, AbbVie

    Accomplished leader with 20+ yrs. of clinical trial experience in oncology, respiratory, and metabolic diseases. Industry expert, consistently delivering programs with high integrity. Adept at influencing stakeholders. Spearheads innovation. Passionate about transforming patient and caregiver experience in clinical trials.A Diversity, Equity and Belonging champion- founder of inclusive research group in Phase I oncology trials at AbbVie and creator of affinity groups within the community.
    A suitcase-loathing adventurer. A Tiny Human’s Personal Assistant.

    Session Details:

    PANEL DISCUSSION: Where Should You Run Your Next Clinical Trial? Opportunities And Challenges in USA, APAC And Beyond

    2027-02-10, 9:30 AM

    Session Details:

    FIRESIDE CHAT: What Sponsors Still Get Wrong About Patient-Centered Clinical Research

    2027-02-10, 12:15 PM

    View In Agenda
    Next speaker
    Back
    Dave Borbas
    VP Research, Head of Data Management, Abcuro

    David Borbas is Research VP, Head of Data Management of Abcuro

    Prior to Abcuro, David worked for more than 25 years of Data Management and Information Technology experience. He has broad experience starting and developing Data Management groups at SurroMed, Millennium Pharmaceuticals South San Francisco and Jazz Pharmaceuticals. After leaving Jazz Pharmaceuticals he provided Data Management consulting services to small and medium size companies in the Bay Area, throughout the US and Canada. He has been involved in 5 successful NDAs and together with Data Management team members has managed more than 100 studies. His research experience includes Rare Disease, Cardiac, Oncology, Rheumatology, Fibromyalgia, Gene Therapy, Neurology and Psychiatry clinical studies. He has supported clinical studies phase 1 to 4 including Global Phase 3 Studies, IVRS and eDiary applications. In addition, David has clinical experience more than 15 years of clinical and management experience in the areas of Critical Care, Emergency, Hemodialysis and Critical Care Transport. He has a Bachelor of Science in Nursing from the University of Pennsylvania and a Master of Science in Information Systems from Claremont Graduate University. He has given presentations at the CDISC International Interchange and supported the Bay Area CDISC meetings and PhUSE standards work groups.

    Session Details:

    Beyond the AI Pilot: Scaling AI Across Clinical Development

    2027-02-10, 12:15 PM

    Session Details:

    PANEL DISCUSSION: Future-Proofing Clinical Trials with AI

    2027-02-10, 2:30 PM

    View In Agenda
    Next speaker
    Back
    Yuyi Shen
    Vice President, Technical Operations, Abcuro

    Experienced and self-motivated process development scientist and team leader with specialty in process improvement, scale up, technical transfer to bioprocess manufacturing in cGMP environment. Strong subject matter experts in design robust processes for protein purification with monoclonal antibody, antigen and VLP etc, ensuring Critical Quality Attributes are achieved.

    Solid trouble shooting and problem solving skills and encouraging innovation technology to achieve high efficiency and avoid repetitive work.

    Strong proven track of define, design, manage and deliver projects upon all milestones, goals and cost target.

    Build, develop, train and supervise team members and engage and motivate members to ensure the overall success and growth.

    Session Details:

    PANEL DISCUSSION: Why Clinical Trial Start-Up Still Takes So Long

    2027-02-10, 2:30 PM

    View In Agenda
    Next speaker
    Back
    Charisse Eary
    Executive Director, Head of Quality, Aligos Therapeutics

    Session Details:

    When is the Right Time to Build Quality Management Systems

    2027-02-10, 4:00 PM

    View In Agenda
    Next speaker
    Back
    Margot L. Goodkin
    Vice President, Ophthalmology Clinical Development, Annexon

    Session Details:

    LIVE DEBATE: Are Too Many AI Tools Holding Back Clinical Development?

    2027-02-11, 9:30 AM

    Session Details:

    PANEL DISCUSSION: Taking Control of Your CRO Strategy

    2027-02-11, 12:15 PM

    View In Agenda
    Next speaker
    Back
    Guinevere Valencia
    Associate Director, Global Patient Advocacy, Argenx

    Session Details:

    FIRESIDE CHAT: What Sponsors Still Get Wrong About Patient-Centered Clinical Research

    2027-02-10, 12:15 PM

    View In Agenda
    Next speaker
    Back
    Malinda Longphre
    Head of Clinical Operations, Attovia Therapeutics

    Malinda Longphre is Head of Clinical Operations at Attovia Therapeutics, where she oversees the execution of early-phase clinical programs. With over 25+ years' experience in biotech and pharma (BMS, Bayer, Aerovance, Oriel, Novartis, Connect), she has led complex global studies and driven cross-functional collaboration between Clinical Operations, CMC, and supply chain teams to ensure efficient and high-quality trial execution. She is a strong advocate for streamlined processes and strategic planning to accelerate development opportunities. Malinda holds a PhD from Johns Hopkins University and trained at UCSF prior to entering industry.

    Session Details:

    PANEL DISCUSSION: Where Should You Run Your Next Clinical Trial? Opportunities And Challenges in USA, APAC And Beyond

    2027-02-10, 9:30 AM

    View In Agenda
    Next speaker
    Back
    Meghal Vakil
    Director, Regulatory Affairs, BeOne Medicines USA

    Session Details:

    PANEL DISCUSSION: Where Should You Run Your Next Clinical Trial? Opportunities And Challenges in USA, APAC And Beyond

    2027-02-10, 9:30 AM

    Session Details:

    ASK THE EXPERTS: The Regulatory Questions You Should Have Asked Six Months Ago

    2027-02-10, 2:30 PM

    View In Agenda
    Next speaker
    Back
    Pamela Contag
    CEO and President, BioEclipse Therapeutics

    Session Details:

    CASE STUDY: When You Stop a Trial Midway, What Changes When You Start Again?

    2027-02-10, 12:15 PM

    View In Agenda
    Next speaker
    Back
    Abhijit Ramachandran
    Director, Clinical Development Operations – Oncology, Corcept Therapeutics

    Abhijit Ramachandran, Director of Clinical Operations at Corcept Therapeutics Inc. is an established versatile leader with deep experience in clinical trial operations management. Expertise in conducting and coordinating multi-center international clinical trials and managing cross-functional project teams. Highly skilled in liaising with Contract Research Organizations (CROs) and other suppliers to achieve program and company goals. Adept at managing the progress of clinical studies and ensuring adherence to study protocols, regulatory/internal SOPs, intended timelines, and budget. Solid experience with early and late-phase clinical studies, including orphan disease indications.

    Session Details:

    PANEL DISCUSSION: Taking Control of Your CRO Strategy

    2027-02-11, 12:15 PM

    View In Agenda
    Next speaker
    Back
    Catherine Caserza
    Director, Clinical Operations, Daiichi Sankyo

    Session Details:

    Navigating Complexity: Reimagining Study Management in High-Stake Clinical Trials

    2027-02-10, 11:15 AM

    View In Agenda
    Next speaker
    Back
    Christian Rubio
    Executive Director, EverythingALS

    Session Details:

    PATIENT ORGANIZATION SPOTLIGHT – Placebo-Less Trials for Deadly Diseases: Building Regulatory-Grade Data Sets That Can Be Used for Clinical Trials

    2027-02-10, 4:00 PM

    View In Agenda
    Next speaker
    Back
    Axel Van Chee
    Associate Director, Investigator Budgets & Payments – Clinical Operations, Exelixis

    Session Details:

    The Cost of Delay: How Contracts and Budgets Can Make or Break Trial Timelines

    2027-02-11, 9:30 AM

    View In Agenda
    Next speaker
    Back
    Christopher Shinn
    Senior Director and Counsel, Contracts, Exelixis

    Session Details:

    The Cost of Delay: How Contracts and Budgets Can Make or Break Trial Timelines

    2027-02-11, 9:30 AM

    View In Agenda
    Next speaker
    Back
    Meghan McKenzie
    Director, AIR Portfolio Alliance Lead, Population Science, Genentech

    Meghan McKenzie is a Director of Health Equity and Clinical Research at Genentech, Inclusion and Belonging Office. She develops strategies to drive greater inclusion of underrepresented patient populations in clinical research and to advance health equity by working directly with sites in our Advancing Inclusive Research (AIR) Site Alliance and by gaining patient insights to change behavior and protocols.

    Gaining patient, clinician and community insights early in program development is integral to developing what is important to patients and improving access to medicines and treatments for all patients, regardless of race, ethnicity, sexual orientation, gender identity, age, disability and socioeconomic status.

    She has over 25 years of clinical development research experience working at the site, CRO and biotech level, and spanning multiple diseases, including oncology, ophthalmology, immunology, neurology, infectious and rare diseases.

    Meghan received her Master’s Degree in Human Biology at San Francisco State University and her Bachelor’s Degree in Economics at University of North Carolina, Chapel Hill and has earned the Cornell University ‘Advanced D&I Certificate’ and the Columbia Business School ‘Certificate in Business Excellence

    Session Details:

    Session reserved

    2027-02-11, 11:15 AM

    View In Agenda
    Next speaker
    Back
    Justin Chickles
    CEO, Glycyx
    Next speaker
    Back
    Mamatha Reddy
    Executive Director and Head of Clinical Operations, Infinimmune

    Session Details:

    TRACK A: How Can We Make Patient Participation Easier?

    2027-02-10, 4:40 PM

    View In Agenda
    Next speaker
    Back
    Megan L. Dunham
    Associate Director, Clinical Data Innovation, Jazz Pharmaceuticals

    Session Details:

    Don’t Bolt a Jet Engine to the Horse Carriage: Designing AI-Native Workflows for Clinical Development

    2027-02-10, 11:15 AM

    Session Details:

    PANEL DISCUSSION: Why Innovation Fails to Scale at the Pilot Stage

    2027-02-11, 12:15 PM

    Session Details:

    TRACK B: Beyond the Hype: Where Does AI Actually Belong in Clinical Trials?

    2027-02-10, 4:40 PM

    View In Agenda
    Next speaker
    Back
    Sue Naim
    Senior Vice President, Clinical Operations, Mirum Pharmaceuticals

    Session Details:

    PANEL DISCUSSION: Taking Control of Your CRO Strategy

    2027-02-11, 12:15 PM

    View In Agenda
    Next speaker
    Back
    Omer Siddiqui
    Venture Partner and Senior Development Advisor, NeuroVC

    Session Details:

    VC SPOTLIGHT Standing Out in a Competitive and Crowded Clinical Trial Landscape

    2027-02-11, 12:15 PM

    View In Agenda
    Next speaker
    Back
    Michael Weickert
    Ph.D, CEO, Pacylex Pharmaceuticals

    Session Details:

    Doing More with Less: How Virtual Biotechs Can Successfully Conduct First Clinical Studies on a Budget

    2027-02-10, 11:15 AM

    View In Agenda
    Next speaker
    Back
    Shilpen Patel
    Senior Vice President, Perspective Therapeutics

    Session Details:

    ASK THE EXPERTS: The Regulatory Questions You Should Have Asked Six Months Ago

    2027-02-10, 2:30 PM

    View In Agenda
    Next speaker
    Back
    Jenny Holt
    Chief Development Officer, Ray Therapeutics

    Session Details:

    PANEL DISCUSSION: Why Innovation Fails to Scale at the Pilot Stage

    2027-02-11, 12:15 PM

    View In Agenda
    Next speaker
    Back
    Chitra Sharma
    Senior Vice President, Development, Scribe Therapeutics

    Chitra Sharma is a high-impact biotechnology executive with over 25 years of experience architecting product lifecycles from early-stage development through successful NDA/BLA approvals. A specialist in CMC and global Quality operations, she has pioneered regulatory and development strategies, working for industry titans including Genentech, Roche Bioscience, Cor Therapeutics and Vivus.
    Currently, as SVP of Development at Scribe Therapeutics, she integrates breakthrough innovation with operational excellence.

    Chitra’s expertise spans a sophisticated portfolio of CRISPR, Cell and Gene Therapy, Biologics and small molecules. Over 13 years as a founder and consultant, she served as a premier bridge between scientific discovery and commercial viability for both Fortune 500 firms and agile startups.
    A pragmatic leader with deep technical mastery, Chitra is defined by her ability to scale global operations and build high-performing, compliant organizations that navigate the complexities of international drug development.

    Session Details:

    ASK THE EXPERTS: The Regulatory Questions You Should Have Asked Six Months Ago

    2027-02-10, 2:30 PM

    View In Agenda
    Next speaker
    Back
    Suyash Prasad
    President, Research and Development, Stealth Mode Biotech

    Session Details:

    Session reserved for

    2027-02-11, 9:30 AM

    View In Agenda
    Next speaker
    Back
    Sanjay Mourya
    Senior Director, Clinical Operations, Unicycive Therapeutics

    Session Details:

    When Trials Go Off Track: How Clinical Operations Leaders Recover Timelines, Sites and Study Performance

    2027-02-11, 11:15 AM

    View In Agenda
    Next speaker
    Back
    Nicholas D’Amato
    Director of Clinical Operations, Vaxart

    Session Details:

    Designing for Delivery: Building Operationally Feasible Clinical Trials

    2027-02-10, 4:00 PM

    View In Agenda
    Next speaker
    Back
    Anirban Mukherjee
    Vice President, Strategic Sourcing, Vera Therapeutics

    Session Details:

    PANEL DISCUSSION: Taking Control of Your CRO Strategy

    2027-02-11, 12:15 PM

    Session Details:

    One Trial, Many Partners: Building a Governance Model That Strengthens Vendor Partnerships

    2027-02-11, 2:00 PM

    View In Agenda
    Next speaker
    Back
    Robert Loll
    Senior Vice President, Business Development and Strategic Planning, Praxis

    Robert Loll is the SVP of Business Development & Strategic Planning at Praxis, a full service patient recruitment & retention agency that specializes in optimizing study enrollment for research studies with award-winning creative and superior execution.  Designing and deploying effective patient recruitment campaign strategies since 2004, Robert’s clinical background includes 16+ years providing patient care for top collegiate, Olympic and disabled athletes around the world and working for outpatient rehabilitation companies including Baxter, Caremark and NovaCare.  Robert is an Advisory Board member for The Center for Information and Study on Clinical Research Participation (CISCRP), an independent non-profit organization dedicated to educating and informing the public and patients about clinical research.

    Session Details:

    Chairperson’s opening remarks

    2027-02-10, 8:15 AM

    View In Agenda
    Next speaker

    Advisory Board

    Select a member to learn more

    Back
    Dr Alison McMorn
    Head of Clinical Strategy and Development, LifeArc

    Dr. McMorn is an experienced clinical development researcher with over 25 years of industry experience and has a strong focus in CNS and paediatric drug development. She has worked for both Pharmaceutical Companies and Contract Research Organisations including holding positions at SAR Monitoring Services Ltd, Mundipharma International Ltd and Shire Development Inc. Starting her career at SAR as a Clinical Research Associate (CRA) she subsequently moved to Mundipharma where she was responsible for initiating the first paediatric clinical research program for the company. At Shire Dr. McMorn led, planned and managed global paediatric and adult clinical development programs for a wide variety of indications including psychiatry, pain, gastrointestinal and hepatology across all phases of development (Phase 0 to Phase 4). In addition she was responsible for harmonizing Clinical Trial Administrator (CTA) working practices across all regions for the company. In 2015 Dr. McMorn joined AMO Pharma Ltd, a virtual pharmaceutical company focused predominantly on paediatric neurodevelopmental rare diseases, as VP of Clinical Development. She holds an undergraduate degree in Pharmacology and a PhD in Psychology from the University of Leeds, UK.

    Next
    Back
    Behtash Bahador
    Senior Director, Community Engagement & Partnerships, Center for Information & Study on Clinical Research Participation (CISCRP)

    Behtash Bahador is the Senior Director of Community Engagement & Partnerships at the non-profit organization CISCRP, and holds a Master of Science in Health Communication from the Tufts University School of Medicine. Since 2014, he has collaborated with a range of stakeholder groups to establish and implement patient- and public-centric initiatives across the life-cycle of drug and treatment development. This has included supporting the development of regulatory and cross-disciplinary best practice guidelines, operationalizing key elements of evidence-based public health programing into research engagement activities, and always keeping the needs of patients, participants and the public at the forefront of his work.

    Next
    Back
    Kathleen Cohen
    Vice President, Clinical Development, Marinus Pharmaceuticals

    Kathleen Frenia Cohen is Vice President and Head of Clinical Development Operations at Marinus Pharmaceuticals.  Prior to joining Marinus, she spent 20+ years at PRA Health Sciences in a variety of project management and operational oversite roles. Kathleen graduated from the University of the Science in Philadelphia with a PharmD and completed a post-doctoral fellowship in Pharmacoeconomics and Outcomes Research from Rutgers College of Pharmacy. Kathleen resides in Media, PA.

    Next
    Back
    Aditya Kotta
    VP Business Development, Novotech

    Aditya Kotta is the VP of Business Development for Novotech. He has been with the company since 2018. He has 14 years of experience in the clinical trial industry, working in both Clinical Operations and Business Development. He holds degrees in Biomedical Engineering from Johns Hopkins University and Medical Science from Boston University.

    Next
    Back
    Martin Rodriguez
    Consumer Safety & Evidence Global Quality & Excellence Head, Opella

    Senior executive Leader in Life Science (Biochemist) and Lean/Six Sigma Green-belt certified, with more than 20 year of experience in clinical operations, Operational Excellence (i.e., operational strategy, performance management, process optimization, risk management, Quality-by-Design and team performance), clinical quality, and Service Providers / Outsourcing management.

    I developed, reengineered, automated, and optimized business processes with a risk-based and approach to produce high quality outputs and to ensure regulatory compliance. I led the development, implementation and monitoring of different operational and quality strategies and models including Outsourcing as well as new/ innovative clinical capabilities to fulfill consumers/ patients needs .

    Next
    Back
    Rosalie Filling
    Vice President, Senior Global Head R&D Operations, Keenova

    In her over 25 years of experience, Rosalie “Rosie” Filling has transformed R&D operations in every company she has worked for, developing clear-cut strategies to help advance clinical trials with high-quality operational execution and scientific excellence.

     

    Rosie is the Vice President, Senior Global Head R&D Operations Endo International plc. She is part of the global R&D leadership team and is charged with the coordination and implementation of clinical development strategies for the company’s research and development. She provides strategic direction and oversight of the R&D Operations team, which includes clinical operations, data management, biostatistics, medical writing, clinical supplies, trial master file/inspection readiness and business operations. This integrated team handles the execution of all aspects related to Endo’s clinical trials. Endo has active research and development programs in men’s health, orthopedics, and endocrinology. Beyond these therapeutic areas, the company also has focused development in the areas of sterile injectables and complex generic products.

     

    Rosie’s main focus at all times is on the end users—the patients. Bringing new and, at times, life-saving medications to patients drives Rosie’s sense of purpose.

     

    Rosie joined Endo from Lupin Pharmaceuticals in Blue Bell, PA where she was Senior Director, Head of Clinical Operations, and built the clinical operations organization to support the US and Global R&D Organization. Prior to Lupin, Rosie spent nearly five years at Teva in Frazer, PA where she was the US site head of Clinical Operations and was responsible for the successful delivery of Inhalation, Women’s Health, and Cardiovascular clinical trials. Earlier in her career, Rosie held various roles at Eisai, MGI Pharma and PPD.

     

    Rosie earned her B.S. in Biology with a minor in Chemistry from the University of Pittsburgh.

    Next
    Back
    Edwin van Vulpen
    Executive Director and Head of Clinical Business Development Euro-Asia
    Next

    Plan Your Visit

    Venue

    Hyatt Regency San Francisco Airport 1333 Bayshore Highway Burlingame, California 94010 United States

    Book Your Stay

    Accommodation

    Arena International Events Group “(Arena”) is aware of numerous third-party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings, events attendee lists and selling unsolicited services. It is unclear whether the agencies in question are in possession of such information, or whether they intend to scam unsuspecting customers. Whilst Arena International Events Group pursues such third-party companies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third-party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group..

    2027 Sponsors

    Select a sponsor to learn more

    FEATURED SPONSOR

    SESSION SPONSORS

    Technology Showcase Sponsor

    Prize Draw Sponsor

    Lunch Sponsor

    Lanyards Sponsor

    Tote Bag Sponsor

    EXHIBITORS

    Co-Sponsor

    Resources

    Why partner?

    Contact us to become a partner

    Partnership Opportunities

    We work with you to design a bespoke package to meet your business needs, where you could:

    • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
    • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
      Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
    • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

    Event reach

    • 800+ attendees each year
    • 80% attendees C-suite level

     

    Take a look at our current sponsors

    Media Centre

    Enquiry

    Contact Us

    SPONSORSHIP ENQUIRIES

    Nick McCudden

    Head of OCT Sponsorship

    +61 280 978 126

    SPEAKER ENQUIRIES

    Niki Khoshkbary

    Program Director

    +44 204540 7545

    MARKETING ENQUIRIES

    Karina Gomez

    Head of Marketing

    DELEGATE ENQUIRIES

    Sunny Saikia

    Delegate Manager

    SPONSORSHIP ENQUIRIES

    Head of OCT Sponsorship

    Nick McCudden


    +61 280 978 126

    SPEAKER ENQUIRIES

    Program Director

    Niki Khoshkbary


    +44 204540 7545

    MARKETING ENQUIRIES

    Head of Marketing

    Karina Gomez


     

    DELEGATE ENQUIRIES

    Delegate Manager

    Sunny Saikia